TGFB2 and glaucoma: Together with data correlating aqueous TGF-β2 with high IOP [23], and experimental evidence for the capacity of TGF-β2 to reduce outflow facility when perfused into cultured human anterior segments [24], the implication of aqueous TGF-β2 in the pathogenesis of the ocular hypertension in glaucoma is compelling.